Healthcare provider profile · identity verified

Jeffrey S Bock, MD

Family Practice · ABERDEEN, SD · NPI 1649274481

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	682	211
Levothyroxine Sodium	Levothyroxine Sodium	573	145
Lisinopril	Lisinopril	518	156
Amlodipine Besylate	Amlodipine Besylate	447	136
Omeprazole	Omeprazole	427	113
Simvastatin	Simvastatin	347	96
Metoprolol Succinate	Metoprolol Succinate	287	77
Metoprolol Tartrate	Metoprolol Tartrate	287	86
Furosemide	Furosemide	268	71
Eliquis	Apixaban	261	55
Metformin Hcl	Metformin Hcl	260	99
Rosuvastatin Calcium	Rosuvastatin Calcium	205	64
Potassium Chloride	Potassium Chloride	194	42
Citalopram Hbr	Citalopram Hydrobromide	181	43
Gabapentin	Gabapentin	178	48
Losartan Potassium	Losartan Potassium	166	56
Tamsulosin Hcl	Tamsulosin Hcl	155	48
Hydrochlorothiazide	Hydrochlorothiazide	149	45
Finasteride	Finasteride	118	48
Sertraline Hcl	Sertraline Hcl	111	35
Clopidogrel	Clopidogrel Bisulfate	110	31
Allopurinol	Allopurinol	101	28
Glipizide	Glipizide	101	36
Carvedilol	Carvedilol	98	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	32
Raloxifene Hcl	Raloxifene Hcl	88	25
Pantoprazole Sodium	Pantoprazole Sodium	86	26
Mirtazapine	Mirtazapine	79	21
Trulicity	Dulaglutide	71	18
Warfarin Sodium	Warfarin Sodium	70	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	67	17
Ropinirole Hcl	Ropinirole Hcl	65	11
Doxazosin Mesylate	Doxazosin Mesylate	59	16
Meloxicam	Meloxicam	55	17
Venlafaxine Hcl Er	Venlafaxine Hcl	55	11
Trazodone Hcl	Trazodone Hcl	53	15
Duloxetine Hcl	Duloxetine Hcl	50	14
Fluticasone Propionate	Fluticasone Propionate	50	16
Montelukast Sodium	Montelukast Sodium	48	11
Buspirone Hcl	Buspirone Hcl	47	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	13
Zolpidem Tartrate	Zolpidem Tartrate	46	20
Atenolol	Atenolol	45	15
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	43	suppressed
Famotidine	Famotidine	41	13
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Valsartan	Valsartan	39	15
Benazepril Hcl	Benazepril Hcl	38	12
Levetiracetam	Levetiracetam	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	15
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Sucralfate	Sucralfate	33	11
Donepezil Hcl	Donepezil Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	17
Baclofen	Baclofen	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Arnuity Ellipta	Fluticasone Furoate	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Flecainide Acetate	Flecainide Acetate	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Niacin Er	Niacin	25	suppressed
Bupropion Hcl	Bupropion Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	13
Ibandronate Sodium	Ibandronate Sodium	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Ozempic	Semaglutide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Verapamil Er	Verapamil Hcl	22	suppressed
Cephalexin	Cephalexin	21	19
Pregabalin	Pregabalin	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Clonazepam	Clonazepam	18	11
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Trospium Chloride	Trospium Chloride	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Nabumetone	Nabumetone	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Eplerenone	Eplerenone	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Levonorgestrel-Eth Estradiol	Levonorgestrel/Ethin.Estradiol	13	suppressed
Primidone	Primidone	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Naratriptan Hcl	Naratriptan Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Silodosin	Silodosin	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Digoxin	Digoxin	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Verapamil Er Pm	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error